MedTrace Logo

Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury

NCT00596765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2016-05-25

No results posted yet for this study

Summary

Acquired brain injury can result in impaired everyday functioning as well as psychosocial problems, including depressive symptoms, irritability, or negative self-concept. The purpose of this study is to determine whether a combination of neuropsychological and cognitive behavioral therapy is effective in the treatment of these sequelae.

Conditions

  • Brain Injury

Interventions

BEHAVIORAL

Neuropsychological Cognitive Behavioral Therapy

Neuropsychological Cognitive Behavioral Therapy encompasses 2 foci: First emphasis is on neuropsychological compensatory strategies for the treatment of deficits in attention, memory, and executive functions. Secondly, cognitive behavioral intervention techniques are employed to support the patient in the process of coping with chronic illness: i.e. improve regulation of negative affect, diversify the impaired self-concept after acquired brain injury, and adjust important life-goals to changed circumstances.

Sponsors & Collaborators

  • Psychotherapie-Ambulanz Marburg e.V.

    collaborator OTHER

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Cornelia Exner, Dr. (PhD) · Philipps University Marburg, Department of Clinical Psychology and Psychotherapy

  • Winfried Rief, Prof. Dr. · Philipps University Marburg, Department of Clinical Psychology and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2014-10-31
Completion
2015-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00596765 on ClinicalTrials.gov